Home > Income Statement > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Total Expenditure

    Back to Income Statement
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Total Expenditure History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Total Expenditure ₹315 Cr₹283 Cr₹252 Cr₹241 Cr₹118 Cr

What is the latest Total Expenditure of NATH BIOGENES (INDIA) ?

The latest Total Expenditure ratio of NATH BIOGENES (INDIA) is ₹315 Cr based on Mar2025 Consolidated results.
Year Total Expenditure
Mar2025₹315 Cr
Mar2024₹283 Cr
Mar2023₹252 Cr
Mar2022₹241 Cr
Mar2013₹118 Cr

How is Total Expenditure of NATH BIOGENES (INDIA) Trending?

Years Total Expenditure % Change
Mar2025 ₹315 Cr
11.42
Mar2024 ₹283 Cr
12.00
Mar2023 ₹252 Cr
4.66
Mar2022 ₹241 Cr
104.70
Mar2013 ₹118 Cr -

Compare Total Expenditure of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹295.2 Cr -3.7% -0.7% -18.5% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹13,180.3 Cr 1.6% 2.8% -11.5% Stock Analytics
KAVERI SEED COMPANY ₹5,071.9 Cr 1.1% -0.9% 8.8% Stock Analytics
VENKYS (INDIA) ₹2,137.1 Cr 2.6% 10.7% -18.1% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,108.9 Cr -7.4% 0.8% -27.5% Stock Analytics
INDO US BIOTECH ₹245.0 Cr 1.1% -2.8% -54.1% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-3.7%

-0.7%

-18.5%

SENSEX

-0.4%

-0.6%

8.6%


You may also like the below Video Courses